{"id":739424,"date":"2023-03-13T07:48:28","date_gmt":"2023-03-13T11:48:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/"},"modified":"2023-03-13T07:48:28","modified_gmt":"2023-03-13T11:48:28","slug":"biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/","title":{"rendered":"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <b>MAINZ, <\/b><br \/>\n        <b>Germany<\/b><br \/>\n        <b>, March 13, 2023<\/b><br \/>\n        <b>(GLOBE NEWSWIRE)<\/b> \u2013 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CFQcehQ8U-_qMjUO9P-0NtgPQTQzDekduA6Bho4mEtk513Qc3i0zM7tyAIshMHJQCjK13iPTY12n2zvrUwfqFQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>BioNTech SE<\/u><\/a> (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the full year and fourth quarter 2022 on Monday, March 27<sup>th<\/sup>, 2023. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the fourth quarter and full year 2022.\u00a0<\/p>\n<p align=\"justify\">To access the live conference call via telephone, please register via this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6hC1MiX76LZMCCk73gNDBVt5JX3XUFXvA1iseX5_uf2UbsXzn1wWbIGS4BJXp3JtBP6vbSTe2lYOMjtC_A8rL1skfI0_n2p57wMqxRdR3g6jvw8comJdM3dyYCkvYBnxa_KkVgiO8Mhpha76t7G0mw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>link<\/u><\/a>. Once registered, dial-in numbers and a pin will be provided. It is recommended to register at least a day in advance.<\/p>\n<p align=\"justify\">The slide presentation and audio of the webcast will be available via this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6hC1MiX76LZMCCk73gNDBYrdKOYcVJLJMG_Z1XuNEcHzMAQQdRdKJqB-thDdyodbWlpmjfJJDz7uk7MR0JyzLuE0bA7Ga23ZRRJ1PVjrxSo=\" rel=\"nofollow noopener\" target=\"_blank\"><u>link<\/u><\/a>.<\/p>\n<p align=\"justify\">Participants may also access the slides and the webcast of the conference call via the \u201cEvents &amp; Presentations\u201d page of the Investor Relations section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uCOwegYS3mmK1ydgSelTnsFN7EizLw9MOf9KkV_376RulaB7ywWPmtu7rRnw0bImzw_tLE5Sq_3KgJzwbwsCUw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.BioNTech.com<\/u><\/a>. A replay of the webcast will be available shortly after the conclusion of the call and archived on the Company\u2019s website for 30 days following the call.<\/p>\n<p align=\"justify\">\n        <b>About BioNTech <\/b><br \/>\n        <br \/>Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bispecific immune checkpoint modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uCOwegYS3mmK1ydgSelTno5KJc1SZ_HVnCgZi9r_W3sk-pF3OhnKYLMGDKHg46vyLRhXIAF_N1euc1Mm4WqbyQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.BioNTech.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <b>BioNTech Contacts<\/b>\n      <\/p>\n<p align=\"justify\">\n        <b>Investor Relations<\/b><br \/>\n        <br \/>Michael Horowicz\u00a0<br \/>+1 (617) 955 7420<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oTRp9vLItPTwIQzsaOdisdhvIT0n7FgYVzki_DKhHh49YgJckc2CkoqiUt64go0sn8LEGhCDEspScuDs0WosXPbH2-gYpTMXF8GmY1768oU=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Investors@biontech.de<\/u><\/a><\/p>\n<p align=\"justify\">\n        <b>Media Relations<\/b><br \/>\n        <br \/>Jasmina Alatovic<br \/>+49 (0)6131 9084 1513<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_SjrUpAXeTd23clDOCWXKpr7wXckCFkzVcFIe0gJdy-cYMTupMeKdO6ukHqeEp6aqn4O4FzxNGcI3cvB08Y7RpS6JKDYpKtr1uNBbzIZpkI=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Media@biontech.de<\/u><\/a><\/p>\n<p>\n        \n      <\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZTI0NzBjMmYtYWNlYy00YTExLTg0NTUtNTg2YjlmYzU2MDUxLTEwMTI1NTg=\/tiny\/BioNTech-SE.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MAINZ, Germany , March 13, 2023 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the full year and fourth quarter 2022 on Monday, March 27th, 2023. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the fourth quarter and full year 2022.\u00a0 To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a pin will be provided. It is recommended to register at least a day in advance. The slide presentation and audio &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-739424","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MAINZ, Germany , March 13, 2023 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the full year and fourth quarter 2022 on Monday, March 27th, 2023. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the fourth quarter and full year 2022.\u00a0 To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a pin will be provided. It is recommended to register at least a day in advance. The slide presentation and audio &hellip; Continue reading &quot;BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-13T11:48:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023\",\"datePublished\":\"2023-03-13T11:48:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/\"},\"wordCount\":353,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/\",\"name\":\"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==\",\"datePublished\":\"2023-03-13T11:48:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/","og_locale":"en_US","og_type":"article","og_title":"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023 - Market Newsdesk","og_description":"MAINZ, Germany , March 13, 2023 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the full year and fourth quarter 2022 on Monday, March 27th, 2023. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the fourth quarter and full year 2022.\u00a0 To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a pin will be provided. It is recommended to register at least a day in advance. The slide presentation and audio &hellip; Continue reading \"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-13T11:48:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023","datePublished":"2023-03-13T11:48:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/"},"wordCount":353,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/","name":"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==","datePublished":"2023-03-13T11:48:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc5NzcxMyM0MDE1MDgzMDAjMjAwMDk4NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-full-year-and-fourth-quarter-2022-financial-results-and-operational-update-on-march-27-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=739424"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739424\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=739424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=739424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=739424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}